Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer.
Tonyali O, Benekli M, Berk V, Coskun U, Ozkan M, Yildiz R, Ucgul E, Sevinc A, Uncu D, Demirci U, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Tonyali O, et al. Among authors: yildiz r. J Cancer Res Clin Oncol. 2013 Jun;139(6):981-6. doi: 10.1007/s00432-013-1409-1. Epub 2013 Mar 5. J Cancer Res Clin Oncol. 2013. PMID: 23463098 Clinical Trial.
Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer.
Coskun U, Alkis N, Celenkoglu G, Buyukberber S, Ozkan M, Camci C, Uner A, Er O, Aslan UY, Sevinc A, Tokluoglu S, Ozturk B, Yildiz R, Benekli M; Anatolian Society of Medical Oncology. Coskun U, et al. Among authors: yildiz r. J Natl Med Assoc. 2009 Aug;101(8):761-4. doi: 10.1016/s0027-9684(15)31003-8. J Natl Med Assoc. 2009. PMID: 19715037
Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer.
Kaya AO, Buyukberber S, Benekli M, Coskun U, Sevinc A, Akmansu M, Yildiz R, Ozturk B, Yaman E, Kalender ME, Orhan O, Yamac D, Uner A; Anatolian Society of Medical Oncology (ASMO). Kaya AO, et al. Among authors: yildiz r. Med Oncol. 2010 Mar;27(1):152-7. doi: 10.1007/s12032-009-9186-z. Epub 2009 Feb 26. Med Oncol. 2010. PMID: 19242825
Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.
Kefeli U, Buyuberber S, Akyol M, Yildiz R, Kaplan MA, Ciltas A, Sevinc A, Karaca H, Seker M, Ozdemir N, Alacacioglu A, Coskun U, Isikdogan A, Dane F, Gumus M, Ozkan M, Suner A, Tarhan MO, Benekli M. Kefeli U, et al. Among authors: yildiz r. Hepatogastroenterology. 2013 Jun;60(124):647-52. doi: 10.5754/hge12692. Hepatogastroenterology. 2013. PMID: 23165189
Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer.
Yildiz R, Benekli M, Ozkan M, Alkis N, Berk V, Kaplan MA, Ciltas A, Karaca H, Durnali AG, Coskun U, Dikilitas M, Sevinc A, Dane F, Yetisyigit T, Dogu GG, Buyukberber S. Yildiz R, et al. J Cancer Res Clin Oncol. 2012 Nov;138(11):1845-52. doi: 10.1007/s00432-012-1264-5. Epub 2012 Jun 22. J Cancer Res Clin Oncol. 2012. PMID: 22722713
Co-existence of gastrointestinal stromal tumors with other primary neoplasms.
Sevinc A, Seker M, Bilici A, Ozdemir NY, Yildiz R, Ustaalioglu BO, Kalender ME, Dane F, Karaca H, Gemici C, Gumus M, Buyukberber S. Sevinc A, et al. Among authors: yildiz r. Hepatogastroenterology. 2011 May-Jun;58(107-108):824-30. Hepatogastroenterology. 2011. PMID: 21830398
191 results